Table 3. Comprehensive comparison of therapeutic domains, outcomes, and limitations for PCI versus CABG

Domain PCI CABG
Typical indication Focal, technically approachable stenosis; poor surgical targets; bridge to surgery Diffuse multivessel or left-main disease; aneurysm-complex anatomy
Main advantages Less invasive; rapid recovery; preserves future options Arterial graft patency; comprehensive treatment of complex proximal disease
Main limitations Malapposition risk across ectatic/aneurysmal segments; reintervention; calcification may require RA Sternotomy; peri-operative risks; growth issues in children
Long-term signals KD RA series: event-free survival ≈ 79% at 10 y; ≈ 39% at 20 y (small samples) [16] National survey (Japan, 2008–2019): 30-day mortality 0.9%; 10-year survival 94% [11]
Practical tip IVUS/OCT optimization; distal-reference sizing; use PET-MFR for complex physiology ITA-first strategy; heart-team planning
PCI: percutaneous coronary intervention; CABG: coronary artery bypass grafting; RA: rotational atherectomy; IVUS: intravascular ultrasound; OCT: optical coherence tomography; PET-MFR: positron emission tomography–derived myocardial flow reserve; ITA: internal thoracic artery.